How much cash does Core Laboratories generate?

Core Laboratories (CLB) generated $34.3M in operating cash flow over the trailing twelve months.

What is Core Laboratories's free cash flow?

After $11.9M of capital expenditures, Core Laboratories's free cash flow was $22.5M over the trailing twelve months, down 51.1% year over year.

Where does Core Laboratories's cash flow data come from?

Every line is extracted from Core Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Core Laboratories CLB Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	$30.39M-5.5%	$32.15M-13.2%	$37.03M+72.2%	$21.5M+6.3%
Depreciation and amortization	$14.65M-2.0%	$14.95M-5.3%	$15.78M-8.0%	$17.16M-7.3%
Stock-based compensation	$7.14M—	——	$13.97M—	——
Deferred income taxes	-$1.42M-111%	-$674K—	——	——
Impairment charges	——	——	——	$0—
Provision for credit losses	——	——	——	——
Change in accounts receivable	——	——	——	——
Change in inventories	-$2.64M+71.8%	-$9.37M—	——	——
Change in accounts payable	——	$519K+104%	-$13.1M—	——
Change in accrued liabilities	——	——	——	——
Change in other assets	$1.2M-78.9%	$5.67M+391%	-$1.95M—	——
Change in other liabilities	-$5.06M—	——	——	——
Other working capital changes	——	$1.12M+376%	-$406K—	——
Change in deferred revenue	-$3.78M-183%	$4.58M—	——	——
Pension contributions	——	-$33K+96.3%	-$892K-298%	$451K+293%
Net cash from operating activities	$37.03M-34.3%	$56.39M+126%	$25M—	——
Capital expenditures	$11.21M-5.7%	$11.89M+12.4%	$10.58M+3.6%	$10.22M-24.5%
Proceeds from sale of property, plant and equipment	$3.02M+73.7%	$1.74M+258%	$485K—	——
Net cash from investing activities	-$2.23M+65.1%	-$6.39M—	——	——
Dividends paid	$1.87M-0.4%	$1.88M+0.4%	$1.87M—	——
Repurchases of common stock	$12.43M+134%	$5.31M+141%	$2.2M—	——
Proceeds from issuance of debt	$48M+9.1%	$44M-78.2%	$202M—	——
Repayments of debt	$63M-23.2%	$82M-61.1%	$211M—	——
Other financing activities	-$255K—	$0+100%	-$54K—	——
Net cash from financing activities	-$31.26M+32.0%	-$45.96M—	——	——
Net increase (decrease) in cash	——	——	-$308K—	——
Interest paid	$8.18M-24.6%	$10.86M-3.0%	$11.2M—	——
Income taxes paid	$18.74M+6.6%	$17.58M—	——	——
Asset write-downs	——	——	$1.14M—	$0—
Increase (Decrease) in Deferred Income Taxes	-$1.42M-111%	-$674K—	——	——
Increase Decrease In Insurance Assets	$1.94M—	——	——	——
Increase (Decrease) in Other Operating Assets	-$28K-110%	$289K—	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	$1.2M-78.9%	$5.67M+391%	-$1.95M—	——
Inventory write-downs	$2.43M-21.2%	$3.08M+79.4%	$1.72M+1,311%	-$142K—
Net Recovery Provision For Doubtful Accounts	$3.42M+184%	$1.2M+572%	$179K+3,083%	-$6K+97.7%
Other Noncash Income (Expense)	——	$1.12M+376%	-$406K—	——
Provision for Loan, Lease, and Other Losses	——	——	——	——
Payment Of Capital Expenditures Rebuilding Of Aberdeen Facility	$3.38M+196%	$1.14M—	$0—	——
Payments Proceeds From Patents And Other Intangibles	$150K+850%	-$20K+70.1%	-$67K—	——
Proceeds From Non Life Insurance Policies	$9.95M+373%	$2.1M—	——	$583K-19.7%
Proceeds from disposals of property, plant and equipment	$3.02M+73.7%	$1.74M+258%	$485K—	——
Other, net	-$255K—	$0+100%	-$54K—	——
Business Acquisition Contingent Cash Consideration	$4.08M—	$0—	$0—	——
Accrued payables for capital expenditures	——	$1.67M—	——	——
Increase Decrease In Contract With Customer Liability	-$3.78M-183%	$4.58M—	——	——
Restricted Shares Withheld From Employees For Settlement Of Tax Liabilities	$3.06M—	$0—	$0—	——
Free cash flow	$25.82M-42.0%	$44.5M+213%	$14.21M—	——
Free cash flow	$25.82M-42.0%	$44.5M+213%	$14.21M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Core Laboratories.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Core Laboratories generate?: Core Laboratories (CLB) generated $34.3M in operating cash flow over the trailing twelve months.
What is Core Laboratories's free cash flow?: After $11.9M of capital expenditures, Core Laboratories's free cash flow was $22.5M over the trailing twelve months, down 51.1% year over year.
Where does Core Laboratories's cash flow data come from?: Every line is extracted from Core Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.